The most honest assessment is that it helps prevent deficiencies and supports overall health during GLP-1 therapy, but it will not dramatically accelerate weight loss, eliminate all side effects, or replace the need for a nutrient-dense diet
Kesavadev J, Ashik A, Yasmin S, Raj KS, Krishnan G, Basanth A, et al
Injectable semaglutide is widely used due to its established dosing profile and predictable absorption
Clinical Trials and Research Supporting Semaglutides Safety Extensive clinical trials involving thousands of patients have backed the safety and effectiveness of semaglutide
DPP-4 inhibitors (gliptins such as sitagliptin or linagliptin) and GLP-1 receptor agonists (such as semaglutide, dulaglutide, or liraglutide) enhance glucose-dependent insulin secretion and are associated with low hypoglycaemia risk